Response Genetics (RGDX) shares climbed in Monday’s pre-market session, after a late-Friday regulatory filing showed activist investor Becker Drapkin cut its stake last week in the developer of clinical diagnostic tests for cancer. RGDX was up 8.5% at $1.40 in recent pre-market trading, in a 52-week range of $1.09 to $2.93. The filing showed Becker…
MSC Industrial \EPS Beat Expectations by $0.02, March Accelerates as Expected
Overall, this was a fairly strong report from MSC with a nice rebound in March, as we expected. The strong growth in March appears to be driven by manufacturing, government, and national accounts. Management’s tone remains upbeat and our sense is that growth could continue to accelerate in the back half. Easy comparisons are a…
- 1
- 2